MedEngine Oy announced today that Saku Torvinen, PhD, joins MedEngine Oy as Director of Market Access. At MedEngine, he will be responsible for the launch…
Tero Ylisaukko-oja11/03/2021
Vedolizumab may have a corticosteroid sparing effect in real-world clinical practice, a new Finnish study reveals. The incidence of inflammatory bowel disease (IBD), which include ulcerative colitis…
Tero Ylisaukko-oja15/02/2019
MedEngine Oy, a company specialized in high-quality medical data science services, and BC Platforms AG, a world leader in genomic data management and analytics, today…
Tero Ylisaukko-oja09/01/2019
Finland is in a good position to begin building a globally competitive ecosystem for real-world data (RWD) research, a qualitative survey conducted by MedEngine reveals.…
Tero Ylisaukko-oja19/12/2018
Suomalaiset lääkealan asiantuntijapalveluihin erikoistuneet DRA Consulting Oy ja MedEngine Oy ovat aloittaneet Pohjoismaat kattavan yhteistyön. Yritysten keskeisenä tavoitteena on kehittää entistä tehokkaampia Market Access -palveluita…
Tero Ylisaukko-oja04/10/2018
MedEngine, a premium service provider for pharmaceutical and health technology industries, reports a strong financial result in 2017. The company’s revenue grew 61% to 1.6…
Tero Ylisaukko-oja22/05/2018
Over the past 10 years, medical affairs has lifted its profile probably more than any other function in the pharmaceutical industry. Currently, medical affairs is…
Tero Ylisaukko-oja12/12/2017
The 20th Annual European Congress of The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) was held in Glasgow, Scotland on Nov 4–8th 2017. The event attracted…
Tero Ylisaukko-oja30/11/2017
The current trend towards a data-driven world is affecting everyone—including the pharmaceutical industry. As the volume and complexity of medical data grows and analytics methods continue developing,…
Tero Ylisaukko-oja22/09/2017
